For more information about this side effect, see Side effect details below
Some people lose significant thigh fat during GLP-1 treatment, particularly those on higher doses of tirzepatide or retatrutide , which can reduce the suitability of this site over time
Use of protein supplements has not yet been adequately evaluated in individuals on GLP-1RAs, but there is evidence that an exercise program may increase the proportion of fat mass loss, as opposed to loss of fat-free mass (124)
(Switzerland) Altimmune (US) Glenmark Pharmaceuticals Ltd (India) Biocon (India) Teva Pharmaceuticals (Israel) MARKET SCOPE WHAT IS IN IT FOR YOU: GLP-1 Agonists Market REPORT CONTENT GUIDE DELIVERED CUSTOMIZATIONS We have successfully delivered the following deep-dive customizations: RECENT DEVELOPMENTS September 2025 : Novo Nordisk (Denmark) received EU approval for its oral GLP-1 receptor agonist drug, Rybelsus, to reduce cardiovascular death, heart attack, and stroke
For the fourth year in a row, cancer is the top condition driving health care cost, which is growing at an astounding rate